Knowledge of presenting features and systemic factors associated with acute NAION is based predominantly on retrospective reports and one prospective treatment trial, with only 258 participants. The Quark / NORDIC NAION treatment trial will recruit 800 participants and the features of the first 400 enrolled provides the largest prospectively uniformly collected dataset on NAION from multiple sites in 8 countries.
Date
2019-03
Language
eng
Format
video/mp4
Source
2019 North American Neuro-Ophthalmology Society Annual Meeting
